Tags: Drug.

Icrucumab is a human monoclonal antibody designed for the treatment of solid tumors.Icrucumab was developed by ImClone Systems Inc.

ATC prefix
none
CAS number
1024603-92-6
FDA UNII code
T7H0B1R64U

Loading...

This page contains content from the copyrighted Wikipedia article "Icrucumab"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.